Clostridium difficile infections in young infants: Case presentations and literature review

Gé-Ann Kuiper1, Joffrey van Prehn2, Wim Ang2

  • 1Department of Pediatrics, Onze Lieve Vrouwe Gasthuis locatie Oost, Amsterdam, The Netherlands.

Idcases
|August 10, 2017
PubMed

Insights

Symptomatic Clostridium difficile infections can occur in young infants, challenging current medical practice. This study highlights cases of C. difficile-associated bloody diarrhea in infants, suggesting it should be considered in diagnosis.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Gastroenterology

Background:

  • Current practice often excludes Clostridium difficile testing in infants under two due to assumed lack of toxin receptors.
  • This assumption is based on limited evidence, primarily from small animal studies.
  • Clostridium difficile infection (CDI) is a significant cause of antibiotic-associated diarrhea in adults.

Purpose of the Study:

  • To investigate the occurrence and clinical presentation of Clostridium difficile infections in neonates and young infants.
  • To challenge the existing clinical practice of not testing young children for CDI.
  • To review existing literature on CDI in children under two years of age.

Main Methods:

  • Presentation of two case studies of infants with recurrent bloody diarrhea post-antimicrobial therapy.
  • Diagnostic testing for toxigenic Clostridium difficile in affected infants.
  • Comprehensive literature review on Clostridium difficile infections in children under two years.

Main Results:

  • Both presented infants showed positive tests for toxigenic Clostridium difficile.
  • Infants were successfully treated with metronidazole and vancomycin.
  • Literature review supports Clostridium difficile as a potential cause of bloody diarrhea in this age group, especially after antibiotic use.

Conclusions:

  • Clostridium difficile infection is a potential cause of bloody diarrhea in neonates and young infants.
  • Previous antimicrobial therapy is a significant risk factor for CDI in this population.
  • Clinical practice should reconsider the exclusion of CDI testing in infants presenting with relevant symptoms.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
388
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.0K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.8K